Biocon Biologics and Serum Institute of Life Sciences have reached an agreement to withdraw from the original equity structure contemplated under their strategic alliance announced in September 2021.
Recommended Articles
View All
homebusiness Newscompanies NewsBiocon Biologics now valued at $6 billion versus $4.9 billion in 2021: Kiran Mazumdar Shaw
Biocon Biologics now valued at $6 billion versus $4.9 billion in 2021: Kiran Mazumdar-Shaw
By Sudarshan Kumar | Apr 25, 2023 11:14 AM IST (Updated)
Mini
Speaking to CNBC-TV18 on the revised agreement with Serum, Kiran Mazumdar-Shaw said, “Investment in Biocon Biologics is now being done at $6 billion valuation. The deal will include the complete portfolio of Serum’s vaccines.”
business | Apr 25, 2023 9:44 AM IST